Huvepharma EOOD, a prominent player in the pharmaceutical industry, is headquartered in Bulgaria (BG) and operates extensively across Europe, North America, and Asia. Founded in 2001, the company has established itself as a leader in the development and production of veterinary pharmaceuticals, with a strong focus on animal health and nutrition. Huvepharma's core offerings include a diverse range of products such as antibiotics, vaccines, and nutritional supplements, all designed to enhance animal welfare and productivity. What sets Huvepharma apart is its commitment to innovation and quality, ensuring that its products meet the highest industry standards. With a robust market position, the company has achieved significant milestones, including numerous regulatory approvals and partnerships that underscore its reputation in the global market.
How does Huvepharma EOOD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Huvepharma EOOD's score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Huvepharma EOOD, headquartered in Bulgaria (BG), currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This often includes setting science-based targets for emissions reductions and committing to initiatives aimed at minimising their carbon footprint. As Huvepharma EOOD continues to operate within this evolving industry context, stakeholders may look forward to future disclosures regarding their carbon emissions and any potential climate commitments they may adopt.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Huvepharma EOOD is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.